scholarly article | Q13442814 |
P50 | author | Sten Vermund | Q42891634 |
Andrew O Westfall | Q44237002 | ||
Benjamin H Chi | Q90251061 | ||
Jeffrey S. A. Stringer | Q90251064 | ||
P2093 | author name string | Albert Mwango | |
Wilbroad Mutale | |||
Ronald A Cantrell | |||
Mohammed Limbada | |||
Lloyd B Mulenga | |||
P2860 | cites work | Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy | Q37355638 |
A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia | Q37357749 | ||
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia | Q42635298 | ||
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia | Q46909093 | ||
The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study | Q47421718 | ||
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. | Q51809092 | ||
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. | Q53645693 | ||
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort | Q83323867 | ||
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review | Q33302944 | ||
Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: a comparison of five different methods | Q33320348 | ||
Development of mental health first aid guidelines for suicidal ideation and behaviour: a Delphi study | Q33325659 | ||
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings | Q33399742 | ||
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. | Q33460434 | ||
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes | Q34556854 | ||
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa | Q37012911 | ||
True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi | Q37084876 | ||
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries | Q37108925 | ||
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia | Q37113579 | ||
Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia | Q37209897 | ||
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Q37265947 | ||
CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia | Q37325907 | ||
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine | Q37351372 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 924-931 | |
P577 | publication date | 2010-03-10 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs | |
P478 | volume | 171 |
Q39838561 | A Prospective Cohort Study of Intimate Partner Violence and Unprotected Sex in HIV-Positive Female Sex Workers in Mombasa, Kenya |
Q39553800 | A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort |
Q39989882 | A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period |
Q33803726 | A simple novel method for determining mortality rates in HIV treatment programs worldwide |
Q33770158 | Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa |
Q34266281 | Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia |
Q33867894 | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
Q36301925 | Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa |
Q24630559 | Combination prevention: new hope for stopping the epidemic |
Q35549179 | Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia |
Q34672929 | Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention? |
Q36386776 | Does provider-initiated counselling and testing (PITC) strengthen early diagnosis and treatment initiation? Results from an analysis of an urban cohort of HIV-positive patients in Lusaka, Zambia |
Q34503222 | Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study |
Q35883654 | Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study |
Q34113515 | Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland |
Q38598283 | Health status, food insecurity, and time allocation patterns of patients with AIDS receiving antiretroviral treatment in South Africa |
Q33746982 | Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system |
Q37138868 | Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU. |
Q37127890 | Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique |
Q40397030 | Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria |
Q37136495 | Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients |
Q35810398 | Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. |
Q34649232 | Loss to follow-up as a competing risk in an observational study of HIV-1 incidence |
Q92758583 | Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015 |
Q37256464 | Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study |
Q37262727 | Mortality and loss to follow-up in the first year of ART: Malawi national ART programme |
Q36708737 | Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. |
Q39013116 | Patient engagement in HIV care and treatment in Zambia, 2004-2014. |
Q36928000 | Predictors of patient attrition according to different definitions for loss to follow-up: a comparative analysis from Lusaka, Zambia |
Q36670625 | Premature adult mortality in urban Zambia: a repeated population-based cross-sectional study |
Q90022761 | Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania |
Q57999164 | Response to: defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition |
Q37368956 | Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar |
Q39283671 | Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria. |
Q37460044 | Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia |
Q36010200 | Survival functions for defining a clinical management Lost To Follow-Up (LTFU) cut-off in Antiretroviral Therapy (ART) program in Zomba, Malawi. |
Q34399340 | Trends in all-cause mortality during the scale-up of an antiretroviral therapy programme: a cross-sectional study in Lusaka, Zambia |
Q34996955 | Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics |
Q30491997 | Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles |
Q34062163 | Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America |
Search more.